T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
GCM Grosvenor
GCMG
$2.85B
| $91K | ﹤0.01% |
+10,120
| New | +$84.3K |
|
|
FRGE
2727
DELISTED
Forge Global Holdings
FRGE
| $90K | ﹤0.01% |
1,735
+114
| +7% | +$4.84K |
|
2728
Grindr
GRND
$2.74B
| $89K | ﹤0.01% |
+10,129
| New | +$68.5K |
|
|
SRT
2729
DELISTED
Startek Inc.
SRT
| $87K | ﹤0.01% |
19,700
+6,900
| +54% | +$29.1K |
|
2730
Angi Inc
ANGI
$196M
| $85K | ﹤0.01% |
3,400
| – | – |
|
2731
Custom Truck One Source
CTOS
$2.33B
| $84K | ﹤0.01% |
13,513
+343
| +3% | +$2.02K |
|
|
CONN
2732
DELISTED
Conn's Inc.
CONN
| $84K | ﹤0.01% |
18,700
| – | – |
|
|
OSG
2733
DELISTED
Overseas Shipholding Group Inc.
OSG
| $84K | ﹤0.01% |
15,858
+1,352
| +9% | +$6.55K |
|
|
ONL
2734
Orion Office REIT
ONL
$161M
| $83K | ﹤0.01% |
14,413
+1,321
| +10% | +$6.89K |
|
2735
Rackspace Technology
RXT
$1.1B
| $83K | ﹤0.01% |
41,215
| – | – |
|
|
IAUX
2736
i-80 Gold Corp
IAUX
$1.43B
| $80K | ﹤0.01% |
45,276
+3,129
| +7% | +$4.81K |
|
|
BFX
2737
DELISTED
BowFlex Inc.
BFX
| $80K | ﹤0.01% |
103,300
| – | – |
|
2738
Alto Ingredients
ALTO
$326M
| $79K | ﹤0.01% |
29,600
| – | – |
|
2739
PDS Biotechnology
PDSB
$13M
| $79K | ﹤0.01% |
15,753
+1,166
| +8% | +$5.8K |
|
|
PRPH
2740
DELISTED
ProPhase Labs
PRPH
| $79K | ﹤0.01% |
1,730
| – | – |
|
2741
Coherus Oncology
CHRS
$176M
| $78K | ﹤0.01% |
23,243
+1,116
| +5% | +$2.99K |
|
2742
Hyliion Holdings
HYLN
$734M
| $78K | ﹤0.01% |
95,506
-44,400
| -32% | -$31.5K |
|
2743
Nano X Imaging
NNOX
$73.2M
| $78K | ﹤0.01% |
12,104
+1,397
| +13% | +$8.72K |
|
2744
PMV Pharmaceuticals
PMVP
$65.1M
| $78K | ﹤0.01% |
24,944
| – | – |
|
|
NVTA
2745
DELISTED
Invitae Corporation
NVTA
| $78K | ﹤0.01% |
123,069
+3,746
| +3% | +$2.24K |
|
|
AMRN
2746
Amarin Corp
AMRN
$299M
| $77K | ﹤0.01% |
4,387
| – | – |
|
|
GAN
2747
DELISTED
GAN Ltd
GAN
| $77K | ﹤0.01% |
48,300
-20,300
| -30% | -$27K |
|
2748
Inovio Pharmaceuticals
INO
$93M
| $77K | ﹤0.01% |
12,500
| – | – |
|
2749
US Global Investors
GROW
$38.8M
| $76K | ﹤0.01% |
26,700
| – | – |
|
2750
Karyopharm Therapeutics
KPTI
$45.1M
| $76K | ﹤0.01% |
5,808
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.